Sunday, November 22, 2009

Alzheimer's Home>
News>
Drugmakers pour $40 million into healthcare reform debate

Font size
- A
- A
- A
Email This

Bookmark

Save

Receive a FREE Osteoarthritis of the knee pamphlet. Start here.

Drugmakers pour $40 million into healthcare reform debate

(NPR) UPDATED 2009-07-24

Statistics show that the Pharmaceutical Research and Manufacturers of America (PhRMA), a lobbying group that represents 32 brandname drug companies, and its member companies have spent $40 million lobbying Congress as the lawmakers work to overhaul the U.S. healthcare system. A report required of all lobbying organizations filed Monday showed that PhRMA spent about $2 million a month in the past three months, a crucial period in the healthcare debate in the House and Senate. But when figures reported from PhRMA's member drug companies is added to the total, it adds up to $40 million spent lobbying Congress during the months of April, May, and June alone. Read full story >

See all Alzheimer's News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Non-Profit Affiliates:

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on OurAlzheimer's.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.